Apr 6th, 2016
Pfizer, Allergan Agree to End $160 Billion Deal
Pfizer Inc. and Allergan Plc agreed to terminate their $160 billion merger, an abrupt end to the largest-ever health-care acquisition as officials in Washington crack down on corporate inversions. Janus Capital Group Director of Research Carmel Wellso and Bloomberg's Drew Armstrong speak on "Bloomberg ‹GO›." (Source: Bloomberg)
